Discover how compounded semaglutide enhances the body's natural insulin function, aiding in blood sugar control and diabetes ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Announcing a new article publication for BIO Integration journal.   Diabetes, a common metabolic condition, poses a substantial health burden worldwide. To revolutionize diabetes management, enhance ...

Insulin receptors are widely expressed and distributed across the brain and are mainly the insulin receptor-A isoform rather than the longer, more prominent isoform IR-B found in the rest of the body.

A recently study published in Nutrients reports that the regular consumption of mangoes may improve inflammation, insulin ...

One of the most exciting developments in diabetes treatment is the use of new medications that help control blood sugar in ...

Tyrosine-protein phosphatase non-receptor type 1 (PTP1B) acts as a negative regulator of the insulin signaling pathway by dephosphorylating both the insulin receptor (IR) and the insulin receptor ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have been ...